{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:03:14Z","timestamp":1789416194038,"version":"build-2803163510"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.critrevonc.2026.105392","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:36:20Z","timestamp":1779780980000},"page":"105392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Exosomes and extracellular vesicles in gastric cancer immune escape"],"prefix":"10.1016","volume":"224","author":[{"given":"Pellegrino","family":"Mazzone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105392_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167821","article-title":"The role of the tumor microenvironment and inflammatory pathways in driving drug resistance in gastric cancer: a systematic review and meta-analysis","author":"Albano","year":"2025","journal-title":"Biochim. Et. Biophys. Acta Mol. Basis Dis."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105392_bib2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrc3304","article-title":"Metastasis. Exosomes drive premetastatic niche formation","volume":"12","author":"Alderton","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105392_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/imr.12519","article-title":"LAG3 (CD223) as a cancer immunotherapy target","volume":"276","author":"Andrews","year":"2017","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105392_bib5","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/s43018-021-00260-2","article-title":"ERK1\/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma","volume":"2","author":"Arrieta","year":"2021","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105392_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004080","article-title":"Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer","volume":"10","author":"Bai","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105392_bib7","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105392_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189275","article-title":"Extracellular vesicles and the tumour microenvironment","volume":"1880","author":"Bel\u00e9nyesi","year":"2025","journal-title":"Biochim. Et. Biophys. Acta Rev. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105392_bib9","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer Journal Clinicians"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/bjc.2011.215","article-title":"Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis","volume":"105","author":"Camargo","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"7517","key":"10.1016\/j.critrevonc.2026.105392_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"issue":"2\u20133","key":"10.1016\/j.critrevonc.2026.105392_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12026-014-8503-6","article-title":"An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation","volume":"58","author":"Casey","year":"2014","journal-title":"Immunol. Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105392_bib13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105392_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186768","article-title":"Extracellular vesicles in the tumour microenvironment: eclectic supervisors","volume":"21","author":"Cavallari","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/cam4.1274","article-title":"Medical management of gastric cancer: a 2017 update","volume":"7","author":"Charalampakis","year":"2018","journal-title":"Cancer Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105392_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000957","article-title":"TIGIT in cancer immunotherapy","volume":"8","author":"Chauvin","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"7718","key":"10.1016\/j.critrevonc.2026.105392_bib17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12253-015-9996-6","article-title":"Clinicopathological variation of lauren classification in gastric cancer","volume":"22","author":"Chen","year":"2016","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.critrevonc.2026.105392_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100682","article-title":"Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors","volume":"50","author":"Dallavalle","year":"2020","journal-title":"Drug Resist. Updates"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105392_bib20","first-page":"175","article-title":"The role of immunotherapy in esophageal and gastric cancer","volume":"22","author":"Dedecker","year":"2023","journal-title":"Clin. Colorectal Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105392_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","article-title":"Helicobacter pylori and gastric cancer: mechanisms and new perspectives","volume":"18","author":"Duan","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105392_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.891652","article-title":"Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches","volume":"12","author":"Emran","year":"2022","journal-title":"Front. Oncol."},{"issue":"31","key":"10.1016\/j.critrevonc.2026.105392_bib24","doi-asserted-by":"crossref","first-page":"E2110","DOI":"10.1073\/pnas.1209414109","article-title":"MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response","volume":"109","author":"Fabbri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105392_bib25","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1245\/s10434-019-07431-7","article-title":"Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis","volume":"26","author":"Fan","year":"2019","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105392_bib26","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/cancers13071742","article-title":"Roles of microRNAs in regulating cancer stemness in head and neck cancers","volume":"13","author":"Fitriana","year":"2021","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105392_bib27","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0016-5085(99)70496-8","article-title":"Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Ga","volume":"116","author":"Fu","year":"1999","journal-title":"stroenterology"},{"key":"10.1016\/j.critrevonc.2026.105392_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2022.01.022","article-title":"Induction and Regulation of the Innate Immune response in Helicobacter pylori Infection","author":"Gobert","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13046-025-03403-w","article-title":"Harnessing engineered extracellular vesicles for enhanced therapeutic efficacy: advancements in cancer immunotherapy","volume":"44","author":"Gong","year":"2025","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105392_bib30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.20517\/cdr.2023.86","article-title":"New mechanisms of multidrug resistance: an introduction to the Cancer Drug Resistance special collection","volume":"6","author":"Gottesman","year":"2023","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.critrevonc.2026.105392_bib31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. & Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105392_bib33","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1177\/00031348221148359","article-title":"Management of gastric cancer","volume":"89","author":"Hall","year":"2023","journal-title":"Am. Surg."},{"key":"10.1016\/j.critrevonc.2026.105392_bib34","article-title":"Clinical significance of the tumor microenvironment on immune tolerance in gastric cancer","volume":"16","author":"He","year":"2025","journal-title":"Front. Immunol."},{"issue":"7578","key":"10.1016\/j.critrevonc.2026.105392_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-019-0967-5","article-title":"The roles of extracellular vesicles in gastric cancer development, microenvironment, anti-cancer drug resistance, and therapy","volume":"18","author":"Huang","year":"2019","journal-title":"Mol. Cancer"},{"issue":"10418","key":"10.1016\/j.critrevonc.2026.105392_bib37","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(23)02033-0","article-title":"Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial","volume":"402","author":"Janjigian","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2026.105392_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217792","article-title":"Harnessing exosomes: From tumor immune escape to therapeutic innovation in gastric cancer immunotherapy","volume":"626","author":"Jin","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105392_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105392_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1603855","article-title":"Exosomal PD-L1 detection in cancer predictive biomarker for response to immune checkpoint blockade therapy","volume":"16","author":"Kansha","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105392_bib41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5230\/jgc.2022.22.e35","article-title":"Molecular pathology of gastric cancer","volume":"22","author":"Kim","year":"2022","journal-title":"J. Gastric Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/febs.15558","article-title":"Exosomes as mediators of immune regulation and immunotherapy in cancer","volume":"288","author":"Kugeratski","year":"2021","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","article-title":"Signaling pathways and therapeutic interventions in gastric cancer","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib44","article-title":"Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions","volume":"10","author":"Liu","year":"2020","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105392_bib45","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41419-024-07191-7","article-title":"PD-L2 of tumor-derived exosomes mediates the immune escape of cancer cells via the impaired T cell function","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death & Dis."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib46","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1186\/s12967-024-05611-y","article-title":"The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib47","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1186\/s12967-025-06883-8","article-title":"The recent progress of tumor cell-derived exosomes in the pathogenesis, diagnosis and therapeutic strategies of tumors","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105392_bib48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fcimb.2017.00417","article-title":"Helicobacter pylori CagA Protein Negatively Regulates Autophagy and Promotes Inflammatory Response via c-Met-PI3K\/Akt-mTOR Signaling Pathway","volume":"7","author":"Li","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105392_bib49","first-page":"4091","article-title":"Exosomal non\u2011coding RNAs: Novel biomarkers with emerging clinical applications in gastric cancer (Review)","volume":"22","author":"Lu","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105392_bib50","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.neo.2017.02.012","article-title":"Chromosomal instability in gastric cancer biology","volume":"19","author":"Maleki","year":"2017","journal-title":"Neoplasia"},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105392_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111735","article-title":"Molecular mechanism for malignant progression of gastric cancer within the tumor microenvironment","volume":"25","author":"Matsuoka","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7559","key":"10.1016\/j.critrevonc.2026.105392_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105392_bib53","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy268.043","article-title":"5-fluorouracil-induced up-regulation of exosomal PD-L1 causing immunosuppression in gastric cancer patients","author":"Min","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105392_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2015.10.009","article-title":"MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma","volume":"53","author":"Mirzaei","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105392_bib55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejca.2022.08.023","article-title":"Recent progress and current challenges of immunotherapy in advanced\/metastatic esophagogastric adenocarcinoma","volume":"176","author":"Moehler","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105392_bib56","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.ymthe.2024.02.025","article-title":"Therapeutic potential of RNA-enriched extracellular vesicles: The next generation in RNA delivery via biogenic nanoparticles","volume":"32","author":"Muskan","year":"2024","journal-title":"Mol. Ther."},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105392_bib57","doi-asserted-by":"crossref","first-page":"10334","DOI":"10.1128\/JVI.01310-13","article-title":"Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells","volume":"87","author":"Nanbo","year":"2013","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105392_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316961","article-title":"Chromosomal instability in gastric cancer: role in tumor development, progression, and therapy","volume":"24","author":"Nemtsova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105392_bib59","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/S1470-2045(14)71016-2","article-title":"Familial gastric cancer: genetic susceptibility, pathology, and implications for management","volume":"16","author":"Oliveira","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ncb2000","article-title":"Rab27a and Rab27b control different steps of the exosome secretion pathway","volume":"12","author":"Ostrowski","year":"2010","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105392_bib61","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105392_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102175","article-title":"Microsatellite instability in Gastric Cancer: Between lights and shadows","volume":"95","author":"Puliga","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.critrevonc.2026.105392_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1327281","article-title":"Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment","volume":"15","author":"Qiu","year":"2024","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105392_bib64","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105392_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072286","article-title":"Extracellular Vesicles and Tumor-Immune Escape: Biological Functions and Clinical Perspectives","volume":"21","author":"Raimondo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105392_bib66","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.2147\/CMAR.S198886","article-title":"Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer","volume":"11","author":"Ren","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105392_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11051312","article-title":"Helicobacter pylori and Its Role in Gastric Cancer","volume":"11","author":"Reyes","year":"2023","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105392_bib68","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1078\/1438-4221-00280","article-title":"Up-regulation of inducible nitric oxide synthase in Helicobacter pylori-associated gastritis may represent an increased risk factor to develop gastric carcinoma of the intestinal type","volume":"293","author":"Rieder","year":"2003","journal-title":"Int. J. Med. Microbiol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105392_bib69","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","article-title":"Cancer stem cell mimicry for immune evasion and therapeutic resistance","volume":"31","author":"Saw","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105392_bib70","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","article-title":"Long noncoding rnas in cancer pathways","volume":"29","author":"Schmitt","year":"2016","journal-title":"Cancer Cell"},{"issue":"6230","key":"10.1016\/j.critrevonc.2026.105392_bib71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105392_bib72","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1093\/annonc\/mdt232","article-title":"HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance","volume":"24","author":"Sheng","year":"2013","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-022-01557-1","article-title":"LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer","volume":"21","author":"Shen","year":"2022","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105392_bib74","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.gene.2014.05.064","article-title":"The effect of Helicobacter pylori CagA on the HER-2 copy number and expression in gastric cancer","volume":"546","author":"Shim","year":"2014","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib75","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1038\/s41598-023-33128-9","article-title":"Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy","volume":"13","author":"Shin","year":"2023","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105392_bib76","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ncb1800","article-title":"Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers","volume":"10","author":"Skog","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4062\/biomolther.2023.196","article-title":"Current development status of cytokines for cancer immunotherapy","volume":"32","author":"Song","year":"2024","journal-title":"Biomol. & Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105392_bib78","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer Journal Clinicians"},{"key":"10.1016\/j.critrevonc.2026.105392_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116182","article-title":"Identification of the exosomal PD-L1 inhibitor to promote the PD-1 targeting therapy of gastric cancer","volume":"268","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105392_bib80","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5867","key":"10.1016\/j.critrevonc.2026.105392_bib81","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1126\/science.1153124","article-title":"Ceramide triggers budding of exosome vesicles into multivesicular endosomes","volume":"319","author":"Trajkovic","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1897-4287-10-18","article-title":"Familial gastric cancer: detection of a hereditary cause helps to understand its etiology","volume":"10","author":"Vogelaar","year":"2012","journal-title":"Hered. Cancer Clin. Pract."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib83","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s11658-024-00676-5","article-title":"Exosome-derived proteins in gastric cancer progression, drug resistance, and immune response","volume":"29","author":"Wang","year":"2024","journal-title":"Cell. & Mol. Biol. Lett."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105392_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108414","article-title":"Helicobacter pylori CagA promotes immune evasion of gastric cancer by upregulating PD-L1 level in exosomes","volume":"26","author":"Wang","year":"2023","journal-title":"IScience"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105392_bib85","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.critrevonc.2026.105392_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1035276","article-title":"Current landscape and future directions of bispecific antibodies in cancer immunotherapy","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105392_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1040163","article-title":"Chronic inflammation, cancer development and immunotherapy","volume":"13","author":"Wen","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105392_bib88","first-page":"2","article-title":"Standardization of sample collection, isolation and analysis methods in extracellular vesicle research","author":"Witwer","year":"2013","journal-title":"J. Extracell. Vesicles"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105392_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121946","article-title":"Exosome-Mediated Immunosuppression in Tumor Microenvironments","volume":"11","author":"Xie","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105392_bib90","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12935-020-1163-9","article-title":"M2 bone marrow-derived macrophage-derived exosomes shuffle microRNA-21 to accelerate immune escape of glioma by modulating PEG3","volume":"20","author":"Yang","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105392_bib91","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.ejca.2009.04.019","article-title":"Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies","volume":"45","author":"Yang","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105392_bib92","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41419-024-06758-8","article-title":"Extracellular vesicles mediated gastric cancer immune response: tumor cell death or immune escape?","volume":"15","author":"Yang","year":"2024","journal-title":"Cell Death & Dis."},{"key":"10.1016\/j.critrevonc.2026.105392_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.117773","article-title":"Exosomal miRNAs from neutrophils act as accurate biomarkers for gastric cancer diagnosis","volume":"554","author":"Yu","year":"2024","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105392_bib94","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.annonc.2021.01.074","article-title":"Exosome-based liquid biopsies in cancer: opportunities and challenges","volume":"32","author":"Yu","year":"2021","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105392_bib95","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:53:51Z","timestamp":1781193231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826002799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":95,"alternative-id":["S1040842826002799"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105392","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomes and extracellular vesicles in gastric cancer immune escape","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105392"}}